Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Mar 30, 2011
Have a look at http://www.cardiumthx.com Generx® is a one-time, non-surgical angiogenic gene therapy being developed by Taxus Cardium (OTC BB: CRXM). This new therapeutic approach employs human growth factor DNA to stimulate the heart's natural ability to grow additional blood vessels (angiogenesis) for patients with advanced coronary artery disease and chest pain (angina pectoris). The therapy is in clinical trials and is intended to offer an innovative non-surgical option for cardiac patients who currently undergo surgical procedures such as balloon angioplasty and stents, or "open heart" cardiac bypass graft surgery (CABG).